ATE534741T1 - Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung - Google Patents

Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Info

Publication number
ATE534741T1
ATE534741T1 AT04805294T AT04805294T ATE534741T1 AT E534741 T1 ATE534741 T1 AT E534741T1 AT 04805294 T AT04805294 T AT 04805294T AT 04805294 T AT04805294 T AT 04805294T AT E534741 T1 ATE534741 T1 AT E534741T1
Authority
AT
Austria
Prior art keywords
strain
leishmania infantum
reduced virulence
protozoan
protozoan strain
Prior art date
Application number
AT04805294T
Other languages
English (en)
Inventor
Da Silva Anabela Cordeira
Ali Ouaissi
Denis Sereno
Jean-Baptiste Vergnes
Original Assignee
Inst Rech Developpement Ird
Univ Do Porto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird, Univ Do Porto filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE534741T1 publication Critical patent/ATE534741T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04805294T 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung ATE534741T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312689A FR2861740B1 (fr) 2003-10-29 2003-10-29 Souches de protozoaire de virulence attenuee et leur utilisation
PCT/FR2004/002735 WO2005044844A2 (fr) 2003-10-29 2004-10-25 Souches de protozoaire de virulence attenuee et leur utilisation

Publications (1)

Publication Number Publication Date
ATE534741T1 true ATE534741T1 (de) 2011-12-15

Family

ID=34429739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805294T ATE534741T1 (de) 2003-10-29 2004-10-25 Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung

Country Status (8)

Country Link
US (1) US7732188B2 (de)
EP (1) EP1678305B1 (de)
AT (1) ATE534741T1 (de)
AU (1) AU2004286879B2 (de)
CA (1) CA2543866A1 (de)
ES (1) ES2393610T3 (de)
FR (1) FR2861740B1 (de)
WO (1) WO2005044844A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
EP2068757B1 (de) 2006-09-14 2011-05-11 Boston Scientific Limited Medizinprodukte mit wirkstofffreisetzender beschichtung
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
EP2187988B1 (de) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprothese mit nicht verschmutzender oberfläche
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
WO2009018340A2 (en) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
EP2185103B1 (de) 2007-08-03 2014-02-12 Boston Scientific Scimed, Inc. Überzug für ein medizinprodukt mit vergrösserter oberfläche
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
FR2924611B1 (fr) * 2007-12-07 2012-10-12 Isabelle Delbosc Nouvelle souche homeopathique comprenant un nosode de protozoaire du genre trypanosoma
US8920491B2 (en) 2008-04-22 2014-12-30 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
EP2303350A2 (de) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprothesen-beschichtung
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
CN114761040A (zh) * 2019-01-09 2022-07-15 港大科桥有限公司 用于增强对疫苗接种的免疫反应和改善疫苗生产的组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7529194A (en) 1993-09-03 1995-03-22 Mcgill University Differentially expressed (leishmania) genes and proteins
US5965143A (en) * 1996-03-12 1999-10-12 Fasel; Nicolas Joseph Immunity to trypanosomatids species
US6162638A (en) 1996-05-06 2000-12-19 Universite Laval Attenuated strains of leishmania and uses thereof
GB9706930D0 (en) 1997-04-04 1997-05-21 Univ Glasgow Leishmania vaccine
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
AU2004286879A1 (en) 2005-05-19
FR2861740A1 (fr) 2005-05-06
WO2005044844A2 (fr) 2005-05-19
CA2543866A1 (fr) 2005-05-19
EP1678305A2 (de) 2006-07-12
WO2005044844A3 (fr) 2005-07-07
EP1678305B1 (de) 2011-11-23
US20070224224A1 (en) 2007-09-27
FR2861740B1 (fr) 2005-12-16
US7732188B2 (en) 2010-06-08
ES2393610T3 (es) 2012-12-26
AU2004286879B2 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
ATE534741T1 (de) Protozoanstamm der spezies leishmania infantum mit reduzierter virulenz und dessen verwendung
IL172506A0 (en) New biological entities and the use thereof
EP1649006A4 (de) Exo-spezifische amylase-polypeptide, diese polypeptide codierende nukleinsäuren und verwendungen davon
NO20080074L (no) Modifiserte mikroorganismer med inaktivert lactat-dehydrogenasegen
ATE449840T1 (de) Alpha-amylasevariante mit veränderten eigenschaften
CR10263A (es) Induccion y estabilizacion de actividad enzimatica en microorganismos
SG142154A1 (en) Methods for genomic analysis
DE602004011497D1 (de) Symbiotische zusammensetzung
CY1108399T1 (el) Τετραϋδροπυριδοθειοφαινια
DK2124573T4 (da) Midesammensætning
DK1842920T4 (da) Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
MX2007002508A (es) Cepas que producen ferulato esterasa y metodos para usarlas.
EP1710300A4 (de) Hochsicheres pocken-vakzine-virus und vaccinia-virus-vektor
EA200600121A1 (ru) Безопасные мутантные вирусные вакцины
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
DE60228089D1 (de) Nukleinsäureamplifikation mit duplexzwischenprodukten
DK1458869T3 (da) Alleler af glucokinasegenet af coryneforme bakterier
MX2023008773A (es) Composicion de vacuna para romper la autotolerancia.
ATE549026T1 (de) Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren
EP1877539A4 (de) Mutanter f. tularensis-stamm und verwendungen davon
PT1603544E (pt) Tratamento de problemas intestinais com n-2,3,3-tetrametilbiciclo 2.2.2. heptan-2-amina
DE10342670A1 (de) Isoliertes Photoprotein mtClytin, sowie dessen Verwendung
WO2002080755A3 (en) Kits and methods for assessing oxidative stress
CY1106661T1 (el) Παγκοσμιως εφαρμοσιμο πλασμα αιματος απενεργοποιημενου ιου που παραγεται απο μεριδια μη καυκασιου πλασματος